115 related articles for article (PubMed ID: 14510947)
1. Prevalence and pattern of antinuclear autoantibodies in 347 patients with non-Hodgkin's lymphoma.
Guyomard S; Salles G; Coudurier M; Rousset H; Coiffier B; Bienvenu J; Fabien N
Br J Haematol; 2003 Oct; 123(1):90-9. PubMed ID: 14510947
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of anticentromere F protein autoantibodies in 347 patients with non-Hodgkin's lymphoma.
Bencimon C; Salles G; Moreira A; Guyomard S; Coiffier B; Bienvenu J; Fabien N
Ann N Y Acad Sci; 2005 Jun; 1050():319-26. PubMed ID: 16014548
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of elevated antinuclear antibody test in patients with Hodgkin's and Non-Hodgkin's lymphoma: a single center experience.
Altintas A; Cil T; Pasa S; Danis R; Kilinc I; Ayyildiz O; Muftuoglu E
Minerva Med; 2008 Feb; 99(1):7-14. PubMed ID: 18299692
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
[TBL] [Abstract][Full Text] [Related]
5. The prevalence and significance of autoantibodies in patients with non-Hodgkin's lymphoma: are they correlated with clinicopathological features?
Bilici A; Yapici HS; Ercan S; Seker M; Ustaalioglu BB; Salman T; Orcun A; Gumus M
J BUON; 2012; 17(3):502-7. PubMed ID: 23033289
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of antinuclear and anti-liver-kidney-microsome type-1 antibodies in patients with chronic hepatitis C in China.
Bai L; Feng ZR; Lu HY; Li WG; Yu M; Xu XY
Chin Med J (Engl); 2009 Jan; 122(1):5-9. PubMed ID: 19187609
[TBL] [Abstract][Full Text] [Related]
7. [Auto-immune manifestations in Non-Hodgkin's lymphoma].
Jardin F; Lévesque H; Tilly H
Rev Med Interne; 2005 Jul; 26(7):557-71. PubMed ID: 15996570
[TBL] [Abstract][Full Text] [Related]
8. Anti-DFS70 antibodies detected by immunoblot methods: A reliable tool to confirm the dense fine speckles ANA pattern.
Bizzaro N; Pesente F; Cucchiaro F; Infantino M; Tampoia M; Villalta D; Fabris M; Tonutti E
J Immunol Methods; 2016 Sep; 436():50-3. PubMed ID: 27374867
[TBL] [Abstract][Full Text] [Related]
9. The significance of autoantibodies in non-Hodgkin's lymphoma.
Timurağaoğlu A; Duman A; Ongüt G; Saka O; Karadoğan I
Leuk Lymphoma; 2000 Dec; 40(1-2):119-22. PubMed ID: 11426612
[TBL] [Abstract][Full Text] [Related]
10. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
[TBL] [Abstract][Full Text] [Related]
11. Detection of serum antinuclear antibodies in lymphoma patients.
Zou HY; Gu X; Yu WZ; Wang Z; Jiao M
Genet Mol Res; 2015 Dec; 14(4):16546-52. PubMed ID: 26681000
[TBL] [Abstract][Full Text] [Related]
12. Antiphospholipid antibodies may be a new prognostic parameter in aggressive non-Hodgkin's lymphoma.
Bairey O; Blickstein D; Monselise Y; Lahav J; Stark P; Prokocimer M; Nativ HM; Kirgner I; Pazgal I; Shaklai M
Eur J Haematol; 2006 May; 76(5):384-91. PubMed ID: 16466368
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of cytokines and prevalence of autoantibodies in lymphoma patients and their prognostic value.
Uskudar Teke H; Gulbas Z; Bal C
J BUON; 2014; 19(1):191-7. PubMed ID: 24659663
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of elevated antinuclear antibodies in patients with diffuse large B-cell lymphoma: A single center study.
Lang J; Ma K; Guo J; Zhang J; Wang Q; Sun H
J Cancer Res Ther; 2018 Jan; 14(1):213-219. PubMed ID: 29516988
[TBL] [Abstract][Full Text] [Related]
15. Circulating CD20 and CD52 in patients with non-Hodgkin's lymphoma or Hodgkin's disease.
Giles FJ; Vose JM; Do KA; Johnson MM; Manshouri T; Bociek G; Bierman PJ; O'Brien SM; Keating MJ; Kantarjian HM; Armitage JO; Albitar M
Br J Haematol; 2003 Dec; 123(5):850-7. PubMed ID: 14632776
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune liver disease-related autoantibodies in patients with biliary atresia.
Pang SY; Dai YM; Zhang RZ; Chen YH; Peng XF; Fu J; Chen ZR; Liu YF; Yang LY; Wen Z; Yu JK; Liu HY
World J Gastroenterol; 2018 Jan; 24(3):387-396. PubMed ID: 29391761
[TBL] [Abstract][Full Text] [Related]
17. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis.
Rueffer U; Josting A; Franklin J; May M; Sieber M; Breuer K; Engert A; Diehl V;
J Clin Oncol; 2001 Apr; 19(7):2026-32. PubMed ID: 11310450
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune disease-associated non-Hodgkin's lymphoma-a large retrospective study from China.
Hu S; Zhou D; Wu Y; Zhao Y; Wang S; Han B; Duan M; Li J; Zhu T; Zhuang J; Cao X; Cai H; Feng J; Zhang Y; Zhang F; Zeng X; Zhao Y; Wang Q; Zhang W
Ann Hematol; 2019 Feb; 98(2):445-455. PubMed ID: 30370485
[TBL] [Abstract][Full Text] [Related]
19. Tissue transglutaminase autoantibodies in patients with non-Hodgkin's lymphoma. Case reports.
Carroccio A; Fabiani E; Iannitto E; Giannitrapani L; Gravina F; Montalto G; Catassi C
Digestion; 2000; 62(4):271-5. PubMed ID: 11070411
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune thyroid disease and autoimmune rheumatic disorders: a two-sided analysis.
Lazúrová I; Benhatchi K; Rovenský J; Kozáková D; Wagnerová H; Tajtáková M; Shoenfeld Y; Macejova Z
Ann N Y Acad Sci; 2009 Sep; 1173():211-6. PubMed ID: 19758153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
